MétaCan
Menu
Back to cohort
Record W4386112777 · doi:10.17615/z01j-zj18

Virologic outcomes among adults with HIV using integrase inhibitor-based antiretroviral therapy

2023· article· en· W4386112777 on OpenAlexfundno aff
P.F. Rebeiro, Huaxiang Lu, M.A. Horberg, M. John Gill, Kate Buchacz, D. Westreich, M.G. Hudgens, Timothy R. Sterling, Michael J. Silverberg, A.A. Adimora, J.J. Eron, J. Li, S.R. Cole, Mari M. Kitahata, J.K. Edwards, R.D. Moore, K.N. Althoff, Viviane D. Lima, Vincent C. Marconi

Bibliographic record

VenueUNC Libraries · 2023
Typearticle
Languageen
FieldMedicine
TopicHIV/AIDS drug development and treatment
Canadian institutionsnot available
FundersNational Institute of Dental and Craniofacial ResearchNational Institute of Neurological Disorders and StrokeNational Institute of Diabetes and Digestive and Kidney DiseasesNational Institute of Allergy and Infectious DiseasesNational Institute on Deafness and Other Communication DisordersNational Institute on Drug AbuseNational Institute of Nursing ResearchNational Institute of Mental HealthNational Heart, Lung, and Blood InstituteNational Institute on AgingCenter for AIDS Research, University of WashingtonCenters for Disease Control and PreventionUniversity of WashingtonJohns Hopkins UniversityViiV HealthcareNational Institutes of HealthNational Cancer InstituteNational Institute on Alcohol Abuse and AlcoholismKaiser PermanenteEmory UniversityCase Western Reserve UniversityUniversity of North Carolina at Chapel HillAgency for Healthcare Research and QualityGovernment of AlbertaCanadian Institutes of Health ResearchVanderbilt UniversityNational Human Genome Research InstituteHealth Resources and Services Administration
KeywordsAntiretroviral therapyIntegraseIntegrase inhibitorHuman immunodeficiency virus (HIV)VirologyMedicineViral load

Abstract

fetched live from OpenAlex

Background: Integrase strand transfer inhibitor (InSTI)-based regimens have been recommended as first-line antiretroviral therapy (ART) for adults with HIV. But data on long-term effects of InSTI-based regimens on virologic outcomes remain limited. Here we examined whether InSTI improved long-term virologic outcomes compared with efavirenz (EFV). Methods: We included adults from the North American AIDS Cohort Collaboration on Research and Design who initiated their first ART regimen containing either InSTI or EFV between 2009 and 2016. We estimated differences in the proportion virologically suppressed up to 7 years of follow-up in observational intention-to-treat and per-protocol analyses. Results: Of 15 318 participants, 5519 (36%) initiated an InSTI-based regimen and 9799 (64%) initiated the EFV-based regimen. In observational intention-to-treat analysis, 81.3% of patients in the InSTI group and 67.3% in the EFV group experienced virologic suppression at 3 months after ART initiation, corresponding to a difference of 14.0% (95% CI 12.4 – 15.6). At 1 year after ART initiation, the proportion virologically suppressed was 89.5% in the InSTI group and 90.2% in the EFV group, corresponding to a difference of -0.7% (95% CI -2.1 to 0.8). At 7 years, the proportion virologically suppressed was 94.5% in the InSTI group and 92.5% in the EFV group, corresponding to a difference of 2.0% (95% CI -7.3 to 11.3). The observational per-protocol results were similar to intention-to-treat analyses. Conclusions: Although InSTI-based initial ART regimens had more rapid virologic response than EFV-based regimens, the long-term virologic effect was similar. Our findings may inform guidelines regarding preferred initial regimens for HIV treatment.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.068
Threshold uncertainty score0.674

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.001
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.023
GPT teacher head0.245
Teacher spread0.222 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2023
Admission routes1
Has abstractyes

Explore more

Same venueUNC LibrariesSame topicHIV/AIDS drug development and treatmentFrench-language works237,207